Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
11 current organization shown on this profile
Board positions
11 supported by public sources, 0 supplied by the profile owner
Committee roles
2Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Highly experienced physician researcher and drug developer with approximately 30 years of clinical research experience, including 19 years in the pharmaceutical industry. Named inventor on numerous granted patents and patent applications.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies

Structured records are unavailable. This does not establish that no records exist.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

UnitedHealth Group

2026-04-21 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

UnitedHealth Group

Open UnitedHealth Group profile →

Director at UnitedHealth Group

2026-04-21 → End not stated

current · source reported

Observed: 2026-09-24

UnitedHealth GroupUnitedHealth GroupVictor Moyo, M.D.

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingLUCD DEF 14A executive officersSupports Executive company, Executive title.Open sourceSource 2 · Sec FilingPAVM DEF 14A executive officersSupports Executive company, Executive title, Other Company Role.Open sourceSource 3 · Sec FilingUNH DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open sourceSource 4 · Sec FilingSSII 10-K executive officersSupports Executive company, Executive title.Open sourceSource 5 · Sec FilingTRAW DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:valerie-montgomery-rice-m-d
Record version
public-0

Published evidence records

7 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. LUCD DEF 14A executive officers

    sec filing · Source published: Apr 30, 2026 · Retrieved: May 16, 2026

    Supports 2 claims
    • Executive company: Executive at Lucid Diagnostics Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 16, 2026

  2. PAVM DEF 14A executive officers

    sec filing · Source published: Apr 30, 2026 · Retrieved: May 16, 2026

    Supports 3 claims
    • Executive company: Executive at PAVmed Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 16, 2026
    • Other Company Role: Victoria T. Lee, M.D. is also linked to Lucid Diagnostics Inc. as Chief Medical Officer. · Claim reviewed: May 16, 2026

  3. UNH DEF 14A director slate

    sec filing · Source published: Apr 21, 2026 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Compensation and Human Resources, Health and Clinical Practice Policies · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Morehouse School of Medicine · Claim reviewed: May 16, 2026
    • Executive title: Executive title: President and CEO · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  4. Open source

    sec filing · Source published: Apr 21, 2026 · Retrieved: May 16, 2026

    Supports 1 claim
    • Professional Role: Director at UnitedHealth Group · Claim reviewed: May 16, 2026

  5. SSII 10-K executive officers

    sec filing · Source published: Mar 10, 2026 · Retrieved: May 16, 2026

    Supports 2 claims
    • Executive company: Executive at SS Innovations International, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Executive Officer Asia Pacific and Director · Claim reviewed: May 16, 2026

  6. TRAW DEF 14A executive officers

    sec filing · Source published: Oct 8, 2025 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at Traws Pharma, Inc. · Claim reviewed: May 16, 2026
    • Executive title: Executive title: Chief Medical Officer, Oncology · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of UnitedHealth Group · Claim reviewed: May 16, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of UnitedHealth Group1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board role · Source reportedBoard role: Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedCommittee assignments: Compensation and Human Resources, Health and Clinical Practice Policies1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at Lucid Diagnostics Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at Morehouse School of Medicine1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at PAVmed Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at SS Innovations International, Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at Traws Pharma, Inc.1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Chief Executive Officer Asia Pacific and Director1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · CorroboratedExecutive title: Chief Medical OfficerSupported by 2 public records2 sources
Verification
Corroborated
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Chief Medical Officer, Oncology1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: President and CEO1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Other Company Role · Source reportedVictoria T. Lee, M.D. is also linked to Lucid Diagnostics Inc. as Chief Medical Officer.1 source
Verification
Source reported
Confidence
70%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources7 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title · Other Company Role

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  4. https://www.sec.gov/Archives/edgar/data/731766/000110465926046125/tm261387-6_def14a.htm

    Sec Filing · Tier not stated · Reviewed May 16, 2026

    Supports: Director at UnitedHealth Group (NYSE: UNH)

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: Executive company · Executive title

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  7. https://www.sec.gov/Archives/edgar/data/731766/000110465926046125/tm261387-6_def14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership